Kowa Pharmaceuticals America Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Kowa Pharmaceuticals America's estimated annual revenue is currently $66.3M per year.(i)
  • Kowa Pharmaceuticals America's estimated revenue per employee is $201,000

Employee Data

  • Kowa Pharmaceuticals America has 330 Employees.(i)
  • Kowa Pharmaceuticals America grew their employee count by -3% last year.

Kowa Pharmaceuticals America's People

NameTitleEmail/Phone
1
CEO & President Reveal Email/Phone
2
CFOReveal Email/Phone
3
VP Trade/Business DevelopmentReveal Email/Phone
4
VP Regulatory & Business OperationsReveal Email/Phone
5
VP HRReveal Email/Phone
6
VP SalesReveal Email/Phone
7
Director, Sales OperationsReveal Email/Phone
8
Director, Sales Training & DevelopmentReveal Email/Phone
9
Chief Medical OfficerReveal Email/Phone
10
Chief Commercial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.9M944%N/AN/A
#2
$10.3M51-28%N/AN/A
#3
$44.8M2237%N/AN/A
#4
$16.5M82-1%N/AN/A
#5
$26.7M1334%N/AN/A
#6
$42M209-3%N/AN/A
#7
$1.4M148%N/AN/A
#8
$66.3M330-3%N/AN/A
#9
$13.9M691%N/AN/A
#10
$32.2M160-10%N/AN/A
Add Company

What Is Kowa Pharmaceuticals America?

Kowa Pharmaceuticals America, Inc. is a specialty pharmaceutical company focused primarily in the areas of cardiology, pain and migraine. A privately held pharmaceutical company headquartered in Montgomery, Alabama, we are focusing our efforts on the acquisition, development, licensing, and marketing of pharmaceutical products. Kowa's entry into the U.S. pharmaceutical market represents a significant step towards its vision of creating a global pharmaceutical organization. KPA is a specialty pharmaceutical company focused on delivering customer solutions for cardiovascular conditions. The privately held company focuses its efforts on the acquisition, development, licensing, and marketing of pharmaceutical products.

keywords:N/A

N/A

Total Funding

330

Number of Employees

$66.3M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kowa Pharmaceuticals America News

2022-04-20 - Migraine Market Size, Growth, Trends [2022-2029] | Global ...

Kowa Pharmaceuticals America. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their...

2022-04-20 - Migraine Drugs Market Size, Outlook And Forecast | Allergan ...

... GlaxoSmithKline, Impax, Abbott, Bayer, Eli Lilly, Ethypharm, Kowa Pharmaceuticals America, Winston Pharmaceuticals, AstraZeneca.

2022-04-17 - Lipid Disorder Treatment Market Size, Scope And Forecast ...

Mylan Pharmaceuticals, Teva Pharmaceuticals, Kowa Pharmaceuticals America Inc., Novartis AG, Pfizer Inc., Astrazeneca Plc, Sun Pharmaceuticals...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$135.3M3307%N/A
#2
$104.7M342N/AN/A
#3
$115.8M3436%N/A
#4
$75M37220%N/A
#5
$15M37814%N/A